SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-054007
Filing Date
2017-09-26
Accepted
2017-09-26 17:15:28
Documents
1
Period of Report
2017-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3915
  Complete submission text file 0001209191-17-054007.txt   5278
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNIQUIRE N.V. 113 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Springhorn Jeremy P. (Reporting) CIK: 0001717852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 171102737